Company: CMND
Filing Date: 2025-12-05
Form Type: F-1/A
Source: 0001213900-25-118772
Chunk: 189

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: F-1/A
Chunk 189
---
 principal executive officers, having a total area of approximately 386 square meters. we occupy approximately 193 square meters of the space for our offices. The rental period is from April 1, 2024 to March 31, 2026. Our base rent was ILS 12,500 per month ($3,400) during the term of the lease. We consider that our current office space is sufficient to meet our anticipated needs for the foreseeable future and is suitable for the conduct of our business. 114 MANAGEMENT Executive Officers and Directors The following table sets forth information regarding our executive officers and directors, including their ages as of October 31, 2025:

| Name                 |     | Age |     | Position                               |
| Dr. Adi Zuloff-Shani |     |  58 |     | Chief Executive Officer                |
| Alan Rootenberg      |     |  73 |     | Chief Financial Officer                |
| Prof. Mark Haden     |     |  72 |     | Vice President of Business Development |
| Amitay Weiss         |     |  64 |     | Chairman of the Board of Directors     |
| Yehonatan Shachar    |     |  35 |     | Director                               |
| Oz Adler             |     |  40 |     | Director                               |
| Asaf Itzhaik         |     |  54 |     | Director                               |
| Hila Kiron-Revach    |     |  45 |     | Director                               |

Dr. Adi Zuloff-Shani, Chief Executive Officer Dr. Adi Zuloff-Shanihas served as our Chief Executive Officer since July 14, 2021. Dr. Zuloff-Shani has more than 20 years of experience as a research and development executive. Dr. Zuloff-Shani has also served as the Chief Technologies Officer of SciSparc Ltd. since February 2016. In addition, Dr. Zuloff-Shani has served as a Member of the Scientific Advisory Board, Save Foods, Inc. (Nasdaq: SVFD) since October 2021, and as Chairman of the board of directors of ORSUS Therapeutics Limited since November 2021. Prior to joining us, and from 2012 to 2016, Dr. Zuloff-Shani served as a vice president development at Macrocure Ltd. (Nasdaq: MCUR) where besides leading all research and development activities